Brief: MiMedx Reports Q4 sales $74.375 Million
28/02/2023 23:24
Feb 28 (Reuters) - MiMedx Q4 operating income USD 1.067 million. * Q4 adjusted EBITDA USD 7.317 million * Q4 gross profit USD 60.006 million * Q4 EBITDA USD 2.043 million * Q4 sales USD 74.375 million * Q4 net income USD -415 thousand
Recent news on MiMedx
See all newsBrief: Mimedx Announces Favorable Federal Court Ruling In Axiofill® Regulatory Classification Matter
MiMedx Group Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Mimedx To Acquire Sanara Medtech
MiMedx Q2 sales fall less than expected; set to acquire Sanara MedTech
Brief: MiMedx Q2 Sales USD 64.362 Million Vs. IBES Estimate USD 63.5 Million